Lynn A. Tetrault, Director at NEOGENOMICS INC (NEO), bought 9,500 shares at $8.21 ($78K) on 2015-12-21, disclosed to the SEC on 2015-12-23.
Open-market purchase of $78k NEO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| NEO | SELL | 2026-06-11 | $60K | — | Filing → |
| NEO | BUY | 2025-05-09 | $114K | — | Filing → |
| RYTM | SELL | 2024-09-11 | $2.0M | — | Filing → |